reviewNature reviews. CancerOct 22, 2010Closed access

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

WPWilliam PaoJCJuliann Chmielecki

Vanderbilt University · Vanderbilt-Ingram Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,070
total citations
FWCI
63.64
Percentile
100%
References
181
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Erlotinib
  • Gefitinib
  • Lung cancer
  • Epidermal growth factor receptor
  • Tyrosine kinase
  • Medicine
  • Disease
  • Cancer research
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding